NCT06915766 2026-03-09Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic MastocytosisCogent Biosciences, Inc.Available
NCT06948955 2026-03-09Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Available
NCT06443944 2026-03-06An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGCG Oncology, Inc.Available